{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:29:13Z","timestamp":1791145753279,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T00:00:00Z","timestamp":1095724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1038\/sj.ijo.0802783","type":"journal-article","created":{"date-parts":[[2004,10,15]],"date-time":"2004-10-15T05:08:33Z","timestamp":1097816913000},"page":"1399-1410","source":"Crossref","is-referenced-by-count":195,"title":["A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects"],"prefix":"10.1038","volume":"28","author":[{"name":"for the OBES-002 Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wilding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Van","family":"Gaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rissanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Vercruysse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fitchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,9,21]]},"reference":[{"issue":"Suppl 4","key":"BF0802783_CR1","doi-asserted-by":"publisher","first-page":"S228","DOI":"10.1038\/oby.2001.123","volume":"9","author":"PT James","year":"2001","unstructured":"James PT, Leach R, Kalamara E, Shayeghi M . The worldwide obesity epidemic. Obes Res 2001; 9 (Suppl 4): S228\u2013S233.","journal-title":"Obes Res"},{"issue":"Suppl 1","key":"BF0802783_CR2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1017\/S000711450000088X","volume":"83","author":"JC Seidell","year":"2000","unstructured":"Seidell JC . Obesity, insulin resistance and diabetes\u2014a worldwide epidemic. Br J Nutr 2000; 83 (Suppl 1): S5\u2013S8.","journal-title":"Br J Nutr"},{"key":"BF0802783_CR3","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jama.286.10.1195","volume":"286","author":"AH Mokdad","year":"2001","unstructured":"Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP . The continuing epidemics of diabetes and obesity in the United States. JAMA 2001; 286: 1195\u20131200.","journal-title":"JAMA"},{"key":"BF0802783_CR4","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1001\/jama.288.14.1723","volume":"288","author":"KM Flegal","year":"2002","unstructured":"Flegal KM, Carroll MD, Ogden CL, Johnson CL . Prevalence and trends in obesity among US adults, 1999\u20132000. JAMA 2002; 288: 1723\u20131727.","journal-title":"JAMA"},{"key":"BF0802783_CR5","doi-asserted-by":"crossref","unstructured":"National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med 2000; 160: 898\u2013904.","DOI":"10.1001\/archinte.160.7.898"},{"key":"BF0802783_CR6","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.7326\/0003-4819-103-6-1006","volume":"103","author":"RJ Garrison","year":"1985","unstructured":"Garrison RJ, Castelli WP . Weight and thirty-year mortality of men in the Framingham Study. Ann Intern Med 1985; 103: 1006\u20131009.","journal-title":"Ann Intern Med"},{"key":"BF0802783_CR7","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1001\/jama.282.16.1530","volume":"282","author":"DB Allison","year":"1999","unstructured":"Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB . Annual deaths attributable to obesity in the United States. JAMA 1999; 282: 1530\u20131538.","journal-title":"JAMA"},{"key":"BF0802783_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/jech.54.8.596","volume":"54","author":"HE Resnick","year":"2000","unstructured":"Resnick HE, Valsania P, Halter JB, Lin X . Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Community Health 2000; 54: 596\u2013602.","journal-title":"J Epidemiol Community Health"},{"key":"BF0802783_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/oby.2000.79","volume":"8","author":"CD Brown","year":"2000","unstructured":"Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, Ernst ND, Horan M . Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000; 8: 605\u2013619.","journal-title":"Obes Res"},{"key":"BF0802783_CR10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/00001648-199607000-00010","volume":"7","author":"JS Kaufman","year":"1996","unstructured":"Kaufman JS, Durazo-Arvizu RA, Rotimi CN, McGee DL, Cooper RS, for the Investigators of the International Collaborative Study on Hypertension in Blacks. Obesity and hypertension prevalence in populations of African origin. Epidemiology 1996; 7: 398\u2013405.","journal-title":"Epidemiology"},{"key":"BF0802783_CR11","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/oxfordjournals.aje.a117385","volume":"141","author":"EB Rimm","year":"1995","unstructured":"Rimm EB, Stampfer MJ, Giovannucci E, Ascherio A, Spiegelman D, Colditz GA, Willett WC . Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 1995; 141: 1117\u20131127.","journal-title":"Am J Epidemiol"},{"key":"BF0802783_CR12","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1001\/jama.1997.03540430051032","volume":"277","author":"KM Rexrode","year":"1997","unstructured":"Rexrode KM, Hennekens CH, Willett WC, Colditz GA, Stampfer MJ, Rich-Edwards JW, Speizer FE, Manson JE . A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997; 277: 1539\u20131545.","journal-title":"JAMA"},{"key":"BF0802783_CR13","first-page":"488","volume":"22","author":"MC Hochberg","year":"1995","unstructured":"Hochberg MC, Lethbridge-Cejku M, Scott Jr WW, Reichle R, Plato CC, Tobin JD . The association of body weight, body fatness and body fat distribution with osteoarthritis of the knee: data from the Baltimore Longitudinal Study of Aging. J Rheumatol 1995; 22: 488\u2013493.","journal-title":"J Rheumatol"},{"key":"BF0802783_CR14","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"J Tuomilehto","year":"2001","unstructured":"Tuomilehto J, Lindstr\u00f6m J, Eriksson JG, Valle TT, H\u00e4m\u00e4l\u00e4inen H, Ilanne-Parikka P, Kein\u00e4nen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, for the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343\u20131350.","journal-title":"N Engl J Med"},{"key":"BF0802783_CR15","doi-asserted-by":"crossref","unstructured":"Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393\u2013403.","DOI":"10.1056\/NEJMoa012512"},{"key":"BF0802783_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/1047-2797(91)90046-F","volume":"1","author":"JA Cutler","year":"1991","unstructured":"Cutler JA . Randomized clinical trials of weight reduction in nonhypertensive persons. Ann Epidemiol 1991; 1: 363\u2013370.","journal-title":"Ann Epidemiol"},{"key":"BF0802783_CR17","first-page":"515","volume":"92","author":"JD Ard","year":"2000","unstructured":"Ard JD, Rosati R, Oddone EZ . Culturally-sensitive weight loss program produces significant reduction in weight, blood pressure, and cholesterol in eight weeks. J Natl Med Assoc 2000; 92: 515\u2013523.","journal-title":"J Natl Med Assoc"},{"key":"BF0802783_CR18","unstructured":"Topiramate (Topamax\u00ae) tablets. Physicians' Desk Reference. Medical Economics Co., Inc: Montvale, NJ; 2002. pp 2590\u20132595."},{"key":"BF0802783_CR19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S0899-9007(00)00452-4","volume":"16","author":"D Richard","year":"2000","unstructured":"Richard D, Ferland J, Lalonde J, Samson P, Deshaies Y . Influence of topiramate in the regulation of energy balance. Nutrition 2000; 16: 961\u2013966.","journal-title":"Nutrition"},{"key":"BF0802783_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/oby.2003.102","volume":"11","author":"GA Bray","year":"2003","unstructured":"Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, Perry BH, for the US Topiramate Research Group. A 6-month randomized, placebo-controlled dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003; 11: 722\u2013733.","journal-title":"Obes Res"},{"key":"BF0802783_CR21","unstructured":"Energy and protein requirements: report of a Joint FAO\/WHO\/UNU Expert Consultation. Technical report series no. 724. World Health Organization: Geneva; 1985. p 71."},{"key":"BF0802783_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/sim.4780100614","volume":"10","author":"CW Dunnett","year":"1991","unstructured":"Dunnett CW, Tamhane AC . Step-down multiple tests for comparing treatments with a control in unbalanced one-way layouts. Stat Med 1991; 10: 939\u2013947.","journal-title":"Stat Med"},{"key":"BF0802783_CR23","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jama.286.11.1331","volume":"286","author":"A Wirth","year":"2001","unstructured":"Wirth A, Krause J . Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 2001; 286: 1331\u20131339.","journal-title":"JAMA"},{"key":"BF0802783_CR24","first-page":"505","volume":"50","author":"IG Smith","year":"2001","unstructured":"Smith IG, Goulder MA, on behalf of the Members of the Sibutramine Clinical Study 1047 Team. Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity. J Fam Pract 2001; 50: 505\u2013512.","journal-title":"J Fam Pract"},{"key":"BF0802783_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jama.281.3.235","volume":"281","author":"MH Davidson","year":"1999","unstructured":"Davidson MH, Hauptman J, DiGirolamo M, Foreyt JP, Halsted CH, Heber D, Heimburger DC, Lucas CP, Robbins DC, Chung J, Heymsfield SB . Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA 1999; 281: 235\u2013242.","journal-title":"JAMA"},{"key":"BF0802783_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2337\/diacare.27.1.155","volume":"27","author":"JS Torgerson","year":"2004","unstructured":"Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L . XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27: 155\u2013161.","journal-title":"Diabetes Care"},{"key":"BF0802783_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","volume":"352","author":"L Sjostrom","year":"1998","unstructured":"Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M . Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998; 352: 167\u2013172.","journal-title":"Lancet"},{"key":"BF0802783_CR28","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","volume":"356","author":"WP James","year":"2000","unstructured":"James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WH, Van Gaal LF . Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000; 356: 2119\u20132125.","journal-title":"Lancet"},{"key":"BF0802783_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","volume":"7","author":"GA Bray","year":"1999","unstructured":"Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML, Seaton TB . Sibutramine produces dose-related weight loss. Obes Res 1999; 7: 189\u2013198.","journal-title":"Obes Res"},{"key":"BF0802783_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2105\/AJPH.90.2.251","volume":"90","author":"KM Carpenter","year":"2000","unstructured":"Carpenter KM, Hasin DS, Allison DB, Faith MS . Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study. Am J Public Health 2000; 90: 251\u2013257.","journal-title":"Am J Public Health"},{"key":"BF0802783_CR31","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/oby.2000.84","volume":"8","author":"F Picard","year":"2000","unstructured":"Picard F, Deshaies Y, Lalonde J, Samson P, Richard D . Topiramate reduces energy and fat gains in lean (Fa\/?) and obese (fa\/fa) Zucker rats. Obes Res 2000; 8: 656\u2013663.","journal-title":"Obes Res"},{"key":"BF0802783_CR32","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S0899-9007(00)00451-2","volume":"16","author":"DA York","year":"2000","unstructured":"York DA, Singer L, Thomas S, Bray GA . Effect of topiramate on body weight and body composition of Osborne\u2013Mendel rats fed a high-fat diet: alterations in hormones, neuropeptide, and uncoupling-protein mRNAs. Nutrition 2000; 16: 967\u2013975.","journal-title":"Nutrition"},{"key":"BF0802783_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/sj.ijo.0801873","volume":"26","author":"D Richard","year":"2002","unstructured":"Richard D, Picard F, Lemieux C, Lalonde J, Samson P, Deshaies Y . The effects of topiramate and sex hormones on energy balance of male and female rats. Int J Obes Relat Metab Disord 2002; 26: 344\u2013353.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0802783_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0920-1211(97)00045-4","volume":"28","author":"HS White","year":"1997","unstructured":"White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH . Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 1997; 28: 167\u2013179.","journal-title":"Epilepsy Res"},{"issue":"Suppl 1","key":"BF0802783_CR35","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1111\/j.1528-1157.2000.tb02164.x","volume":"41","author":"JW Gibbs III","year":"2000","unstructured":"Gibbs III JW, Sombati S, DeLorenzo RJ, Coulter DA . Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 2000; 41 (Suppl 1): S10\u2013S16.","journal-title":"Epilepsia"},{"key":"BF0802783_CR36","first-page":"960","volume":"288","author":"S Taverna","year":"1999","unstructured":"Taverna S, Sancini G, Mantegazza M, Franceschetti S, Avanzini G . Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate. J Pharmacol Exp Ther 1999; 288: 960\u2013968.","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"BF0802783_CR37","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1111\/j.1528-1157.2000.tb06047.x","volume":"41","author":"SJ Dodgson","year":"2000","unstructured":"Dodgson SJ, Shank RP, Maryanoff BE . Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 2000; 41 (Suppl 1): S35\u2013S39.","journal-title":"Epilepsia"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/0802783.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0802783","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0802783.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T03:32:02Z","timestamp":1684207922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/0802783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,21]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["BF0802783"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijo.0802783","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,21]]}}}